Learn how to create CDISC domains in minutes with PK Submit On-Demand Webinar Learn how to create CDISC domains in minutes with PK Submit Creating CDISC domains as part of the pharmacokinetic (PK) deliverable for regulatory submissions can be…CertaraMarch 1, 2023
Understanding Europe’s New Clinical Trial Regulations (EU-CTR) White Paper Understanding Europe’s New Clinical Trial Regulations (EU-CTR) While the new EU-CTR will help to streamline clinical trials, which will benefit both patients…CertaraFebruary 27, 2023
Common Clinical Trial Disclosure Challenges & Potential Solutions Blog Common Clinical Trial Disclosure Challenges & Potential Solutions Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…CertaraFebruary 24, 2023
FDA Modernization Act 2.0 – What does it mean for drug developers? On-Demand Webinar FDA Modernization Act 2.0 – What does it mean for drug developers? Historically, the FDA has required drug discovery and development programs to include animal testing. This…CertaraFebruary 21, 2023
RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act On-Demand Webinar RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…CertaraFebruary 10, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase On-Demand Webinar Data Visualization with SEND Data to See What Happened at the Preclinical Phase SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…CertaraFebruary 9, 2023
A Guide to the UK Regulation of Medicines and Medical Devices Post-Brexit White Paper A Guide to the UK Regulation of Medicines and Medical Devices Post-Brexit CertaraFebruary 8, 2023
Podcast interview with Dr. Elvira Müller. EU joint HTA – decided, but how will it be executed and how should companies prepare Podcast Podcast interview with Dr. Elvira Müller. EU joint HTA – decided, but how will it be executed and how should companies prepare In Europe, there are at least as many reimbursement assessment processes in place as European…CertaraFebruary 7, 2023
FDA awards new grants to support developing & assessing complex generic drugs Announcement FDA awards new grants to support developing & assessing complex generic drugs Certara’s Simcyp physiologically-based pharmacokinetic (PBPK) Simulator is being used to verify and expand biosimulation models…CertaraFebruary 7, 2023
Artificial Intelligence: What is it & how can it accelerate rare disease drug development? Blog Artificial Intelligence: What is it & how can it accelerate rare disease drug development? Large & complex information streams present opportunities for the AI data scientist to aid in…CertaraFebruary 3, 2023